Lifecore Biomedical, Inc. (FRA:LDE)
7.10
-0.20 (-2.74%)
Last updated: Jan 28, 2026, 8:02 AM CET
Lifecore Biomedical Revenue
Lifecore Biomedical had revenue of $19.29M USD in the quarter ending September 30, 2025, with 14.89% growth. This brings the company's revenue in the last twelve months to $74.83M, down -3.47% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $72.33M, down -6.88%.
Revenue (ttm)
$74.83M
Revenue Growth
-3.47%
P/S Ratio
2.41
Revenue / Employee
$184.31K
Employees
406
Market Cap
274.04M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 72.33M | -5.35M | -6.88% |
| May 26, 2024 | 77.67M | -21.57M | -21.74% |
| May 28, 2023 | 99.25M | -12.02M | -10.81% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | 160.07M | -397.49M | -71.29% |
| May 26, 2019 | 557.56M | 33.33M | 6.36% |
| May 27, 2018 | 524.23M | 54.45M | 11.59% |
| May 28, 2017 | 469.78M | -7.14M | -1.50% |
| May 29, 2016 | 476.92M | -62.34M | -11.56% |
| May 31, 2015 | 539.26M | 62.44M | 13.10% |
| May 25, 2014 | 476.81M | 35.11M | 7.95% |
| May 26, 2013 | 441.71M | 124.16M | 39.10% |
| May 27, 2012 | 317.55M | 44.21M | 16.18% |
| May 29, 2011 | 273.34M | 44.95M | 19.68% |
| May 30, 2010 | 228.39M | 3.99M | 1.78% |
| May 31, 2009 | 224.40M | -3.15M | -1.38% |
| May 25, 2008 | 227.55M | 25.66M | 12.71% |
| May 27, 2007 | 201.89M | -23.51M | -10.43% |
| May 28, 2006 | 225.40M | 24.38M | 12.13% |
| May 29, 2005 | 201.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allane SE | 827.69M |
| SIMONA Aktiengesellschaft | 586.42M |
| centrotherm international AG | 288.81M |
| Eleving Group | 203.19M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 171.37M |
| Novabase S.G.P.S. | 130.35M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |
Lifecore Biomedical News
- 15 days ago - Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 18 days ago - Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water - Seeking Alpha
- 18 days ago - Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - Finanz Nachrichten
- 18 days ago - Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - Wallstreet:Online
- 18 days ago - Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - Newsfile Corp
- 23 days ago - Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - Newsfile Corp
- 4 weeks ago - Lifecore Biomedical: The Turnaround Is Just Getting Started - Seeking Alpha